Macroglobulinemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
* [[Waldenström macroglobulinemia]] | * [[Waldenström macroglobulinemia]] | ||
{{SIB}} | |||
[[Category:Signs and symptoms]] | |||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[sv:Makroglobulinemi]] | [[sv:Makroglobulinemi]] | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Revision as of 16:27, 9 January 2009
| Macroglobulinemia | |
| ICD-9 | 273.3 |
|---|---|
| MeSH | D008258 |
Macroglobulinemia is the presence of increased levels of macroglobulins in the circulating blood. A plasma cell dyscrasia resembling leukemia with cells of lymphocytic, plasmacytic, or intermediate morphology, which secrete an immunoglobulin M monoclonal component. There is diffuse infiltration of bone marrow and also, in many cases, of the spleen, liver, or lymph nodes. The circulating macroglobulin produces symptoms of hyperviscosity syndrome: weakness, fatigue, bleeding disorders, and visual disturbances. Peak incidence is in the sixth and seventh decades. (Dorland, 28th ed)